在帕金森病中常见的功能性听力障碍:来自试点研究的见解
Miguel Jose1, Devavrat Nene2, Mathilda Won Yong Choi2
1Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2221 Wesbrook Mall, Vancouver, BC V6T2B5, Canada.
Clinical neurology and neurosurgery
|September 11, 2024
概括
功能性听力损失在帕金森病 (PD) 中很常见,影响超过一半的患者,通常在疾病的早期. 许多患有PD的人不知道他们的听力缺陷,强调需要进一步调查.
科学领域:
- 神经学 神经学
- 听力学 听力学是指听力学.
- 神经科学是一个神经科学.
背景情况:
- 帕金森病 (PD) 中的听力障碍尚未得到充分研究,尽管它可能对沟通和社会互动产生影响.
- 患有PD的患者可能不会感知到听力障碍,掩盖潜在的功能缺陷.
研究的目的:
- 调查PD患者的功能性听力,特别是语音噪音识别.
- 评估功能性听力缺陷和神经精神症状,认知功能和PD患者的生活质量之间的关系.
主要方法:
- 从第三级运动障碍诊所招募了PD的参与者.
- 收集的人口,听力学,神经精神病学和生活质量数据.
- 进行纯音调听力测量 (PTA) 和听力噪音测试 (HINT).
主要成果:
- 在58.6%的参与者中存在功能性听力损失,通常是在疾病的早期 (65%的疾病持续时间<4年).
- 在65.5%的参与者中,纯音调听力测量对年龄来说是正常的,这表明基本听力和功能能力之间存在差异.
- 大多数 (72.4%) 功能性听力损失的人没有感觉到任何听力障碍.
- 听力缺陷与非运动症状,认知或生活质量指标没有相关性.
结论:
- 功能性听力损失是帕金森病早期阶段普遍存在且经常被忽视的问题.
- 对于PD患者听力缺陷的不认识强调了针对性听力学查的必要性.
- 需要进一步的研究,以了解功能性听力损失对PD认知,沟通和生活质量的影响,并开发适当的干预措施.
相关概念视频
Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498


